NASDAQ OMX

Matra Petroleum has been approved for listing on Nasdaq First North and publishes company description

Dela

Matra Petroleum AB (publ) ("Matra Petroleum" or the "Company") has been approved for listing on Nasdaq First North. Trading in Matra Petroleum's shares is planned to commence on 20 April 2017 under the ticker symbol "MATRA". In connection to the listing of the Company shares on Nasdaq First North the Company has prepared a company description (the "Company Description") which as of today is available on Matra Petroleum's website, www.matrapetroleum.com and on Mangold Fondkommission's website www.mangold.se.

The listing on Nasdaq First North
Matra Petroleum believes that the significant decline in the crude oil and gas prices between 2014 and 2016, opens up opportunities for companies with access to capital to acquire and develop low-risk producing oil and gas assets with attractive risk/return characteristics. Matra Petroleum considers that the listing will offer the Company and its shareholders a number of benefits, including:

  • Support for the Company's objective to develop and acquire producing oil and gas properties going forward;
  • Enhancing the profile of Matra Petroleum's business and status with existing and potential business partners;
  • Improved access to the capital market and liquidity for the Company's shareholders; and
  • Increased flexibility in reviewing and capitalizing on growth opportunities.

Background
Earlier in 2017, Matra Petroleum broadened its Swedish shareholder base through a private placement directed to qualified investors and a public offering. In total the Company raised SEK 48.5 million at SEK 10 per share representing a pre-money valuation of SEK 370 million and a fully diluted post money valuation of SEK 415 million.

The Company's CEO Maxim Barskiy is the main shareholder controlling approximately 63% of the Company's shares through companies. The Company's chairman Eric Forss, privately and through company, holds approximately 5% of the shares

Advisors
Mangold Fondkommission AB has acted as financial advisor to the Company in connection with the compilation of the Company Description. Baker McKenzie Advokatbyrå has acted as legal advisor to the Company in connection with the listing in respect of Swedish law.

Certified Adviser
Mangold Fondkommission AB is the Company's Certified Adviser.
Phone: +46 (0) 85 03 01 550
E-mail: info@mangold.se

For more information, please contact:
Eric Forss , Chairman, Matra Petroleum AB
Phone number: +46 8 611 49 95

Investor Relations
Email: IR@matrapetroleum.com

This information is information that Matra Petroleum AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 11 April, 2017, at 14:45 CET.

About Matra Petroleum
Matra is an independent oil and gas exploration and production company operating in the United States where the Company owns and operates 136 leases located in the Texas Panhandle region through its fully owned subsidiary Matra Petroleum Inc. ("Matra USA"). Matra USA was formed in 2013 through a series of mergers and acquisitions in the Texas Panhandle region. Since then, Matra USA has been producing and selling oil and gas in the same area. The Company has grown rapidly and currently owns 38,800 net acres in the Texas Panhandle region with a current daily production of 900 BOEPD and proven net reserves of 22.9 MMboe. Revenues from oil and gas operations amounted to USD 5.7 million (2015: USD 5.5 million) in 2016 and USD 2.0 million in the fourth quarter 2016 (q4 2015: USD 1.1 million).




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Matra Petroleum AB via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste pressmeddelandena från NASDAQ OMX

XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer18.10.2017 16:53Pressmeddelande

AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has begun treatment at Cedars-Sinai Medical Center under the care of Dr. Andrew Hendifar, the Study's Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai. A total of 16 patients are expected to be enrolled in the study. Dr. Hendifar commented, "We are excited to enroll our first patient in this novel combinatorial therapy for the treatment of advanced pancreatic cancer and cachexia. This is the first attempt to add an anti-inflammatory therapy to standard chemotherapy in an effort to improve the performanc

Nasdaq and SGX Establish Collaborative Listings Agreement18.10.2017 15:42Pressmeddelande

NEW YORK and SINGAPORE, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (Nasdaq:NDAQ) and Singapore Exchange (SGX) today announced the signing of a collaborative agreement in a move to leverage their strengths as two of the leading listings venues in the U.S. and Asia respectively. The new agreement seeks to enhance the channels available for companies to access capital market funding and enhance their corporate profile in both markets. As part of this agreement, Nasdaq and SGX -- who also share a successful, long-term market technology relationship -- are currently exploring the demand among corporates for a concurrent or sequential listing on both exchanges. Nasdaq and SGX are committed to supporting companies that are interested in pursuing this route. "The business landscape today is borderless," said Loh Boon Chye, CEO, SGX. "Fast-growing Asian companies looking to tap the capital markets can choose to list on SGX on Asian home ground, and embark on a listing on Nasdaq

Momentum Group acquires remaining 70 percent of Knut Sehlins Industrivaruhus in Örnsköldsvik18.10.2017 15:00Pressmeddelande

TOOLS Sweden (part of Momentum Group) has owned 30 percent of the shares in Knut Sehlins Industrivaruhus AB ("Sehlins") in Örnsköldsvik, Sweden since 2007. Today, TOOLS acquired the remaining 70 percent of the shares in Sehlins, which thus becomes a wholly owned subsidiary. Sehlins generates annual revenue of approximately MSEK 40 and has 14 employees. Sehlins is one of the leading industrial resellers in Örnsköldsvik, an attractive and important market with a number of successful industrial companies. The aim of the acquisition for TOOLS is to continue developing Sehlins as a wholly owned business with a focus on delivering optimal service for existing and potential customers in the local market. Sehlins has been part of TOOLS since the chain was formed in 2003. Closing takes place in October 2017. The acquisition is expected to have a marginal impact on Momentum Group's earnings per share during the current financial year. Stockholm, 18 October 2017

Momentum Group förvärvar resterande 70 procent av Knut Sehlins Industrivaruhus i Örnsköldsvik18.10.2017 15:00Pressmeddelande

TOOLS Sverige (inom Momentum Group-koncernen) är sedan 2007 delägare med 30 procent av aktierna i Knut Sehlins Industrivaruhus AB ("Sehlins") i Örnsköldsvik. TOOLS har idag förvärvat resterande 70 procent av aktierna i Sehlins, vilket härigenom blir ett helägt dotterbolag. Sehlins omsätter cirka 40 MSEK per år och har 14 anställda. Sehlins är en av de ledande industriåterförsäljarna i Örnsköldsvik, en intressant och viktig marknad med ett antal framgångsrika industriföretag. Syftet med TOOLS förvärv är att fortsätta utveckla Sehlins som en helägd verksamhet med fokus på att serva nuvarande och potentiella kunder på den lokala marknaden på bästa sätt. Sehlins har varit en del av TOOLS sedan starten av kedjan 2003. Tillträde sker i oktober 2017. Förvärvet bedöms ha en marginell påverkan på Momentum Groups resultat per aktie under innevarande räkenskapsår. Stockholm den 18 oktober 2017 Momentum Group AB (publ) För ytterligare inf

Colliers International Expands in Washington, D.C.18.10.2017 14:30Pressmeddelande

Acquisition of Beltway Real Estate Services Firm Strengthens Ongoing Commitment to the Region TORONTO and WASHINGTON, Oct.  18, 2017  (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI)(TSX:CIGI) announced today the acquisition of leading tenant representation advisory firm Serten Advisors. With its office in Tysons Corner, the firm serves global, national, and regional clients with a highly skilled and experienced team of professionals that have more than 100 years of combined experience. "This strategic acquisition positions Colliers to gain additional market share and win new business in the vibrant and competitive Suburban DC markets," said Marty Pupil, Colliers International President | U.S. Brokerage. "Adding Steve and Paul and the rest of their talented leadership team to our existing group of professionals in the region will further position Colliers as the commercial real estate services firm of

InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC18.10.2017 14:00Pressmeddelande

InSphero AG / InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the utility of its new 3D InSight(TM) Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs.  The findings will be presented at oral and poster presentations this Friday at the annual meeting of the American Association for the Study of Liver Disease (AASLD) Conference in Washington, DC.  Anti-fibrotic therapi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum